Navigation Links
USC researchers present diabetes findings at American Diabetes Association Scientific Sessions
Date:6/5/2009

New Orleans, LA June 4, 2009---Researchers from the Keck School of Medicine of the University of Southern California will present new findings at the American Diabetes Association's scientific sessions June 5 9 in New Orleans, LA.

Keck School of Medicine of USC faculty, students and post-doctoral fellows will present sessions including helping diabetes patients avoid "post exercise hypoglycemia," the role of pancreatic beta cells in the progression of diabetes, and how the body becomes aware of low blood sugar. The presentations comprise four symposium lectures, 11 poster presentations, 10 oral presentations and three late-breaking poster presentations.

Researchers are available at the meeting to discuss their findings and provide expert commentary on diabetes research.

Exercise

Anne Peters, M.D., professor of medicine and director, USC Westside Center for Diabetes will discuss her research on the management of diabetes treatment, the role of exercise in treatment of diabetes, and patients' vulnerability to post-exercise hypoglycemia.

Peters will discuss recommendations and guidelines including how long diabetes patients should exercise, what type of exercise is most beneficial, and timing medication to avoid a precipitous drop on blood sugar following workouts. The symposium will take place on Saturday, June 6 (Session: Fueling the Serious Athlete, Guidelines/Recommendations for the Prevention and Treatment of Exercise and Post-Exercise Induced Hypoglycemia).

Pancreatic Beta Cell Mass in Development of Diabetes

Tom Buchanan, M.D., professor of medicine, associate dean for clinical research, chief, division of endocrinology and diabetes, and program director for the General Clinical Research Center will discuss his research on the role of pancreatic beta cell mass in the regulation of blood sugar, and whether it is possible to modulate beta cell mass to prevent type 2 diabetes. '/>"/>

Contact: Leslie Ridgeway
leslie.ridgeway@usc.edu
University of Southern California
Source:Eurekalert

Page: 1 2

Related biology news :

1. MSU researchers receive $400,000 in first wave of stimulus funding
2. Researchers engineer metabolic pathway in mice to prevent diet-induced obesity
3. Elevated water temperature and acidity boost growth of key sea star species: UBC researchers
4. Penn researchers discover genetic risk factor for testicular cancer
5. Understanding plants overactive immune system will help MU researchers build better crops
6. Notre Dame researchers describe new tool for evaluating managed relocations
7. UCSD researchers make first direct observations of biological particles in high-altitude ice clouds
8. 3-D kidney atlas created for researchers and physicians
9. Researchers gain genome-wide insights into patterns of the worlds human population structures
10. UMMS researchers isolate first neuroprotective gene in patients with amyotrophic lateral sclerosis
11. NOAA researchers: Blue whales re-establishing former migration patterns

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
(Date:11/24/2009)...bby arteries from collapsing have been true life-s...onger needed -- once the arteries are strengthened... no choice but to leave them in place. , Prof. M...t of Biomedical Engineering has developed a new pa...re they,re needed, then dissolves. , "Our new co...
(Date:11/24/2009)...matter of debate. A high-profile study a few years...their carbon from trees and leaves, evidence for a...ic ecosystems. , But new research from the Unive... true. Algae provide a much richer diet for fish a...shed this week in the Proceedings of the National...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 1Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 2Omega Protein Reports 2009 Second Quarter Results 53906 1Omega Protein Reports 2009 Second Quarter Results 53906 2Omega Protein Reports 2009 Second Quarter Results 53906 3Omega Protein Reports 2009 Second Quarter Results 53906 4Omega Protein Reports 2009 Second Quarter Results 53906 5Omega Protein Reports 2009 Second Quarter Results 53906 6GenVec Reports Second Quarter 2009 Financial Results 13434 1GenVec Reports Second Quarter 2009 Financial Results 13434 2GenVec Reports Second Quarter 2009 Financial Results 13434 3GenVec Reports Second Quarter 2009 Financial Results 13434 4GenVec Reports Second Quarter 2009 Financial Results 13434 5GenVec Reports Second Quarter 2009 Financial Results 13434 6GenVec Reports Second Quarter 2009 Financial Results 13434 7
...nthetically engineered tissues such as muscle or c...orward, Cornell engineers describe in the journal ...e developed that can nourish growing tissues., The...a water-based gel that mimic a vascular system at ...l nutrients and growth factors to feed individual ...
...chi, Ph.D., distinguished professor of human genet...Institute of Human Genetics and a Howard Hughes Me...el Prize in Physiology or Medicine. , The announc...at the Karolinska Institute, in Stockholm, Sweden....ment of knockout mice technology, a gene-targeting...
...earchers at Columbia University Mailman School of ...n dramatically lower blood arsenic levels in indiv...nking water. This toxic element, naturally presen... a significant public health problem in at least 7...s and also parts of the U.S. Chronic arsenic expo...
Other Biology News:Researchers create system to build transplant tissue 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 3Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 2Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 3
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...S, Calif., May 6 Amgen (Nasdaq: AMGN ), today a... Meeting of Stockholders, held at The St. Regis Ho...cent of outstanding shares were represented at the...ore, Frank J. Biondi, Jr., Francois de Carbonnel, ...uck, Frank C. Herringer, Gilbert S. Omenn, Judith ...
...ay 6 ChanTest, the leading expert in ion channels... drug discovery, development, and safety -- is one...through Ohio,s Third Frontier Research and Commerc...terim Director of the Ohio Department of Developme..., Mark Barbash, announced the competitive grants l...
...y 6 /PRNewswire/ - Technology experts from over 20...ns on energy and the environment, topics of global...icromachine Summit is an international forum to di...ologies and the way in which they deliver economic...ue amongst the delegates of scientists, researcher...
Other Biology Technology:Amgen Announces Voting Results Of Annual Meeting Of Stockholders 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3World Micromachine Summit highlights technologies impacting energy and the environment 2
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Silencer siRNA Starter Kit from Ambion
Goat Anti-VAV2 Antibody, Unconjugated from Raybiotech, Inc.
Anti-Indoleamine 2,3-dioxygenase (IDO) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: